Medtech Med’s Industry
South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection
Lunit, a trailblazer in AI-driven diagnostics and cancer treatment, announced significant strides in its European market presence through new...
March 19, 2024 | News
Chipscreen Biosciences Announces Successful Phase II Trial of Chiglitazar for NASH Treatment
The CGZ203 study, a randomized, double-blind, placebo-controlled trial conducted across 24 national clinical sites, aimed to assess the saf...
March 19, 2024 | News
EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices
Under the agreement signed on March 13, 2024, in Bellevue, Washington, EDAN and GH Labs will combine their expertise to create innovative ul...
March 18, 2024 | News
Revvity Launches Revolutionary Newborn Sequencing Workflow to Advance Rare Disease Diagnosis
Revvity, Inc., a pioneering force in genomic sequencing technology, has announced the launch of a groundbreaking "sample-to-answer" workflow tailored speci...
March 18, 2024 | News
BeiGene's TEVIMBRA Wins FDA Nod for Advanced Esophageal Cancer Post-Chemotherapy
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has app...
March 15, 2024 | News
X-Therma Raises $22.4 Million in Series B Funding to Revolutionize Regenerative Medicine and Extend Organ Preservation
X-Therma Inc., an innovator in biotechnology focusing on regenerative medicine and organ preservation, announces the successful completion ...
March 14, 2024 | News
Almirall and Eloxx Pharmaceuticals Forge Exclusive Global License Agreement for Rare Disease Treatment ZKN-013
Almirall, S.A. (BME:ALM), a global biopharmaceutical company, and Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a clinical-stage biopharmaceutical innovator, ha...
March 14, 2024 | News
Genesis MedTech and Silk Road Medical Partner to Treat Carotid Artery Disease in China
Since its establishment in 2019, Genesis MedTech Group has continuously strived to enhance its peripheral interventional portfolio, offering compre...
March 11, 2024 | News
Johnson & Johnson Completes $2 Billion Acquisition of Ambrx Biopharma, Bolstering Oncology Pipeline
Johnson & Johnson (NYSE: JNJ) announced it has successfully completed the acquisition of Ambrx Biopharma, Inc., a clinical-stage biopharmaceutica...
March 08, 2024 | News
BioGate Announces Breakthrough in Pancreatic Cancer Treatment with New Drug BGX
Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...
March 07, 2024 | News
Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy
Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...
March 06, 2024 | News
Cyient Joins Forces with MassMedic to Propel MedTech Innovation
Cyient, a global Intelligent Engineering and Technology Solutions company, is thrilled to announce its membership with the Massachusetts Medical Device Ind...
March 05, 2024 | News
Phagenesis Secures $42M in Series D Funding to Revolutionize Swallowing Dysfunction Treatment
Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a $42M&nbs...
March 05, 2024 | News
Naveris Inc. Launches Pioneering NAVigate-HPV Registry to Enhance HPV Cancer Diagnostics
-Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the launch of the NAVigate-HPV Registry. This innov...
March 04, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
